Johnson & Johnson (JNJ)CEO sold ~$26.7M

~$26.7M

Approx. value · 102K sh @ $261.00

276K

Holds after · shares reported

Traded

Aug 13, 2026

Filed

Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
2. Mar 30, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
3. Apr 10, 2026Federal contract · $198K obligatedDepartment of Defense awarded Johnson & Johnson: $198K obligated to date
4. Jun 2, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
5. Jun 9, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
6. Jun 25, 2026FDAFDA device clearance: Coated VICRYL™ (Polyglactin 910) Plus Antibacterial Suture
7. Jun 25, 2026FDAFDA device clearance: ATTUNE Total Knee System; ATTUNE Cementless Knee System
8. Jun 25, 2026FDAFDA device clearance: VELYS™ Robotic-Assisted Solution
9. Jun 29, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
10. Jul 15, 2026Company filing · Form 8-K · ResultsReported its results
11. Jul 20, 2026InsiderOfficer sold ~$5.79M of JNJ shares in the open market
12. Jul 23, 2026FDARecall: Velys Enabling Tech Robotic-Assist Station REF: 451611001
13. Jul 25, 2026FDAFDA device clearance: MONARCH™ Platform (MON-000008)
14. Jul 27, 2026FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
15. Jul 30, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
16. Jul 30, 2026CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
17. Jul 31, 2026FDARecall: HEALON EndoCoat PRO, REF: 10300012 (US/CAN) HEALON DUET PRO II, REF: 10300016 (US/CAN) HEALON EndoCoat PRO, REF: 10301012 (EU); HEALON DUET PRO II, REF: 103010…
18. Jul 31, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
19. Aug 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.”
20. Aug 5, 2026Insider · 1 personInsiders: 2 sales (~$12.5M)
21. Aug 6, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
22. Aug 12, 2026FDARecall: Automated Impella Controller (AIC) with the below product descriptions and corresponding Product Codes. 1. Impella Controller, Packaged, CA; Product Code: 0042…
23. Aug 12, 2026FDARecall: Impella Optical Controller with the below product descriptions and corresponding Product Codes. 1. Impella Optical Controller, Packaged, AU; Product Code: 0042…
24. Aug 12, 2026FDARecall: Impella Optical Controller, Automated Impella Controller, Impella Connect Package with the below product descriptions and corresponding Product Codes. 1. Optic…
25. Aug 13, 2026 · this disclosureInsiderCEO sold ~$26.7M of JNJ shares in the open market

What came next

1. Aug 13, 2026InsiderCEO sold ~$5.5M of JNJ shares in the open market
2. Aug 17, 2026Insider · Named in an 8-K 13 days earlierOfficer sold ~$3.95M of JNJ shares in the open market
3. Aug 20, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
4. Aug 24, 2026FDAFDA drug approval: Imaavy
5. Aug 27, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
6. Aug 28, 2026FDAFDA drug approval: Stelara
7. Sep 2, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
8. Sep 2, 2026Insider · 1 personInsiders: 2 sales (~$9.2M)
9. Sep 4, 2026FDAFDA device clearance: ATTUNE Revision Knee System
10. Sep 8, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
11. Sep 17, 2026FDAFDA device clearance: HARMONIC 1100 Shears (HAR1120); HARMONIC 1100 Shears (HAR1136)
12. Oct 5, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Joaquin Duato, CEO and Chairman of the Board

• SEC Form 4 at Johnson & Johnson (JNJ)Aug 14, 2026
• SEC Form 4 at Johnson & Johnson (JNJ)Aug 7, 2026
• SEC Form 4 at Johnson & Johnson (JNJ)Aug 7, 2026
• SEC Form 4 at Johnson & Johnson (JNJ)Jan 28, 2026
• SEC Form 4 at Johnson & Johnson (JNJ)Jan 28, 2026

The full history of Joaquin Duato, CEO and Chairman of the Board is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Johnson & Johnson

• House Clerk periodic transaction reportOct 5, 2026
• USAspending.gov award recordOct 5, 2026
• USAspending.gov award recordSep 22, 2026
• USAspending.gov award recordSep 21, 2026
• House Clerk periodic transaction reportSep 12, 2026
• Senate eFD periodic transaction reportSep 11, 2026

Everything OQRO holds on this company is on its JNJ page.